Page last updated: 2024-08-23

sq-11725 and Skin Neoplasms

sq-11725 has been researched along with Skin Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bailey, MT; Crouser, N; Curry, JM; DeVries, AC; Eubank, TD; Glaser, R; Gross, AC; Marsh, CB; Steinberger, KJ; Sumner, LA; Voorhees, JL; Wang, Y; Yang, EV	1
Bautista-Paloma, FJ; Cotrina-Luque, J; Del Vayo-Benito, CA; Flores-Moreno, S; Villalba-Moreno, AM	1
Fruge, JH; Massengale, WT; Rouhana, HF	1

Reviews

1 review(s) available for sq-11725 and Skin Neoplasms

Article	Year
Beta blocker treatment for infantile hemangiomas. Dermatology online journal, 2015, Jul-15, Volume: 21, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015

Article

Year

Beta blocker treatment for infantile hemangiomas.

Dermatology online journal, 2015, Jul-15, Volume: 21, Issue:7

Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome

2015

Other Studies

2 other study(ies) available for sq-11725 and Skin Neoplasms

Article	Year
Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma. Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:9 Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Chemokine CCL2; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Macrophages; Melanoma, Experimental; Mice; Mice, Transgenic; Nadolol; Norepinephrine; Restraint, Physical; Skin Neoplasms; Stress, Psychological; Tumor Microenvironment	2020
Nadolol for the treatment of infantile hemangioma. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Jan-01, Volume: 72, Issue:1 Topics: Adrenergic beta-Antagonists; Blood Pressure; Child, Preschool; Female; Heart Rate; Hemangioma; Humans; Infant; Nadolol; Propranolol; Skin Neoplasms; Treatment Outcome	2015

Article

Year

Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma.

Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:9

Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Chemokine CCL2; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Macrophages; Melanoma, Experimental; Mice; Mice, Transgenic; Nadolol; Norepinephrine; Restraint, Physical; Skin Neoplasms; Stress, Psychological; Tumor Microenvironment

2020

Nadolol for the treatment of infantile hemangioma.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Jan-01, Volume: 72, Issue:1

Topics: Adrenergic beta-Antagonists; Blood Pressure; Child, Preschool; Female; Heart Rate; Hemangioma; Humans; Infant; Nadolol; Propranolol; Skin Neoplasms; Treatment Outcome

2015